1.Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
Kyunghwan OH ; Hee Seung HONG ; Nam Seok HAM ; Jungbok LEE ; Sang Hyoung PARK ; Suk-Kyun YANG ; Hyuk YOON ; You Sun KIM ; Chang Hwan CHOI ; Byong Duk YE ;
Intestinal Research 2023;21(1):137-147
Background/Aims:
We investigated the real-world effectiveness and safety of ustekinumab (UST) as induction treatment for Koreans with Crohn’s disease (CD).
Methods:
CD patients who started UST were prospectively enrolled from 4 hospitals in Korea. All enrolled patients received intravenous UST infusion at week 0 and subcutaneous UST injection at week 8. Clinical outcomes were assessed using Crohn’s Disease Activity Index (CDAI) scores at weeks 8 and 20 among patients with active disease (CDAI ≥150) at baseline. Clinical remission was defined as a CDAI <150, and clinical response was defined as a reduction in CDAI ≥70 points from baseline. Safety and factors associated with clinical remission at week 20 were also analyzed.
Results:
Sixty-five patients were enrolled between January 2019 and December 2020. Among 49 patients with active disease at baseline (CDAI ≥150), clinical remission and clinical response at week 8 were achieved in 26 (53.1%) and 30 (61.2%) patients, respectively. At week 20, 27 (55.1%) and 35 (71.4%) patients achieved clinical remission and clinical response, respectively. Twenty-seven patients (41.5%) experienced adverse events, with serious adverse events in 3 patients (4.6%). One patient (1.5%) stopped UST therapy due to poor response. Underweight (body mass index <18.5 kg/m2) (odds ratio [OR], 0.085; 95% confidence interval [CI], 0.014–0.498; P=0.006) and elevated C-reactive protein at baseline (OR, 0.133; 95% CI, 0.022–0.823; P=0.030) were inversely associated with clinical remission at week 20.
Conclusions
UST was effective and well-tolerated as induction therapy for Korean patients with CD.
2.Corrigendum: Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
Kyunghwan OH ; Hee Seung HONG ; Nam Seok HAM ; Jungbok LEE ; Sang Hyoung PARK ; Suk-Kyun YANG ; Hyuk YOON ; You Sun KIM ; Chang Hwan CHOI ; Byong Duk YE ;
Intestinal Research 2023;21(2):273-273
3.Factors Associated with Clinical Outcomes of Palliative Stenting for Malignant Colonic Obstruction
Sang-Jae KWON ; Jiyoung YOON ; Eun Hye OH ; Jeongseok KIM ; Nam Seok HAM ; Sung Wook HWANG ; Sang Hyoung PARK ; Byong Duk YE ; Jeong-Sik BYEON ; Seung-Jae MYUNG ; Suk-Kyun YANG ; Dong-Hoon YANG
Gut and Liver 2021;15(4):579-587
Background/Aims:
Self-expandable metal stents (SEMSs) can be applied to relieve colorectal obstruction secondary to incurable primary colorectal cancer or extracolonic malignancy. We aimed to identify factors associated with clinical success and the reintervention-free survival (RFS) after palliative stenting.
Methods:
Cases of palliative SEMS placement between 2005 and 2019 were retrieved from the institutional database and reviewed retrospectively. Logistic regression and log-rank testing followed by Cox proportional hazard analyses were performed to investigate the predictors of the clinical success of palliative stenting and factors associated with RFS, respectively.
Results:
A total of 593 patients underwent palliative stenting for malignant colonic obstruction (MCO). The technical and clinical success rates were 92.9% and 83.5%, respectively. Peritoneal carcinomatosis was a predictor of clinical failure (odds ratio, 0.33; 95% confidence interval [CI], 0.17 to 0.65) in the multivariate analysis. Peritoneal carcinomatosis (hazard ratio [HR], 2.48; 95% CI, 1.69 to 3.64) and stent expansion >90% on day 1 (HR, 1.62; 95% CI, 1.05 to 2.50) were associated with a shorter RFS. Neither clinical success nor RFS was associated with extracolonic malignancy. Re-obstruction, stent migration, and perforation were responsible for most reinterventions after clinically successful palliative stenting.
Conclusions
In patients requiring palliative stenting for MCO, peritoneal carcinomatosis was associated with both clinical failure and short RFS. Stent expansion >90% on postprocedural day 1 was another predictor of a short RFS after clinically successful stenting. A large prospective study is warranted to establish factors associated with RFS after successful palliative stenting for MCO.
4.Factors Associated with Clinical Outcomes of Palliative Stenting for Malignant Colonic Obstruction
Sang-Jae KWON ; Jiyoung YOON ; Eun Hye OH ; Jeongseok KIM ; Nam Seok HAM ; Sung Wook HWANG ; Sang Hyoung PARK ; Byong Duk YE ; Jeong-Sik BYEON ; Seung-Jae MYUNG ; Suk-Kyun YANG ; Dong-Hoon YANG
Gut and Liver 2021;15(4):579-587
Background/Aims:
Self-expandable metal stents (SEMSs) can be applied to relieve colorectal obstruction secondary to incurable primary colorectal cancer or extracolonic malignancy. We aimed to identify factors associated with clinical success and the reintervention-free survival (RFS) after palliative stenting.
Methods:
Cases of palliative SEMS placement between 2005 and 2019 were retrieved from the institutional database and reviewed retrospectively. Logistic regression and log-rank testing followed by Cox proportional hazard analyses were performed to investigate the predictors of the clinical success of palliative stenting and factors associated with RFS, respectively.
Results:
A total of 593 patients underwent palliative stenting for malignant colonic obstruction (MCO). The technical and clinical success rates were 92.9% and 83.5%, respectively. Peritoneal carcinomatosis was a predictor of clinical failure (odds ratio, 0.33; 95% confidence interval [CI], 0.17 to 0.65) in the multivariate analysis. Peritoneal carcinomatosis (hazard ratio [HR], 2.48; 95% CI, 1.69 to 3.64) and stent expansion >90% on day 1 (HR, 1.62; 95% CI, 1.05 to 2.50) were associated with a shorter RFS. Neither clinical success nor RFS was associated with extracolonic malignancy. Re-obstruction, stent migration, and perforation were responsible for most reinterventions after clinically successful palliative stenting.
Conclusions
In patients requiring palliative stenting for MCO, peritoneal carcinomatosis was associated with both clinical failure and short RFS. Stent expansion >90% on postprocedural day 1 was another predictor of a short RFS after clinically successful stenting. A large prospective study is warranted to establish factors associated with RFS after successful palliative stenting for MCO.
5.Impact of Bone Mineral Density on the Incidence of Age-Related Vertebral Fragility Fracture
Jeongik LEE ; Geunwu CHANG ; Hyun KANG ; Dae-Woong HAM ; Jae-Sung LEE ; Hyoung Seok JUNG ; Kwang-Sup SONG
Journal of Korean Medical Science 2020;35(17):e116-
Background:
Vertebral fragility fracture (VFF) is a common fracture related to osteoporosis. However, VFF might be asymptomatic and often occurs in patients without osteoporosis. Therefore, we investigated the characteristics of age-related VFF and their correlation with bone mineral density (BMD). Furthermore, we analyzed other factors affecting VFF
Methods:
Medical records from a single center were retrospectively reviewed for 2,216 patients over 50 years old with vertebral fractures conservatively treated from 2005 to 2016. Patients' age, gender, body mass index (BMI), BMD, fracture level, previous vertebral fractures, and anti-osteoporosis medications were obtained. Patients were divided into fragilityon-fragility groups and age sub-groups. The odds ratio for VFF in relation to BMD was evaluated. We also identified other predictive factors for VFF by age groups.
Results:
The fragility group had a higher women ratio, older age, lower BMI, lower BMD, and greater incidence of previous vertebral fractures than the non-fragility group. VFFs were seen in 41.18% of normal BMD patients aged 50–59 and 67.82% of those aged 60–69. The proportion of VFFs increased with age in all WHO osteoporosis classifications. Patients with osteopenia and osteoporosis were 1.57 and 2.62 fold more likely to develop VFFs than normal BMD. In the younger group (under 70), age, women, BMD, and previous vertebral fracture were significant factors affecting VFF, and in the older group (70 and over), age, women, and BMD were factors. In the fragility group, anti-osteoporosis medication rates were 25.08% before and 45.96% after fracture.
Conclusion
Considerable VFFs occurred in the younger age groups without osteoporosis and age itself was another important predictor of VFF especially in older age groups. The discrepancy between the incidence of VFF and BMD suggests the necessity of supplemental screening factors and anti-osteoporosis treatment guidelines using only BMD should be reconsidered.
6.Reversal of Hypoglycemia Unawareness with a Single-donor, Marginal Dose Allogeneic Islet Transplantation in Korea: A Case Report.
Hae Kyung YANG ; Dong Sik HAM ; Heon Seok PARK ; Marie RHEE ; Young Hye YOU ; Min Jung KIM ; Ji Won KIM ; Seung Hwan LEE ; Tae Ho HONG ; Byung Gil CHOI ; Jae Hyoung CHO ; Kun Ho YOON
Journal of Korean Medical Science 2015;30(7):991-994
Pancreatic islet transplantation is a physiologically advantageous and minimally invasive procedure for the treatment of type 1 diabetes mellitus. Here, we describe the first reported case of successful allogeneic islet transplantation alone, using single-donor, marginal-dose islets in a Korean patient. A 59-yr-old patient with type 1 diabetes mellitus, who suffered from recurrent severe hypoglycemia, received 4,163 islet equivalents/kg from a single brain-death donor. Isolated islets were infused intraportally without any complications. The immunosuppressive regimen was based on the Edmonton protocol, but the maintenance dosage was reduced because of mucositis and leukopenia. Although insulin independence was not achieved, the patient showed stabilized blood glucose concentration, reduced insulin dosage and reversal of hypoglycemic unawareness, even with marginal dose of islets and reduced immunosuppressant. Islet transplantation may successfully improve endogenous insulin production and glycemic stability in subjects with type 1 diabetes mellitus.
Blood Glucose/analysis
;
Diabetes Mellitus, Type 1/*surgery
;
Female
;
Humans
;
Hypoglycemia/*surgery
;
Immunosuppression/methods
;
Immunosuppressive Agents/therapeutic use
;
Islets of Langerhans/physiology/*surgery
;
Islets of Langerhans Transplantation/*methods
;
Middle Aged
;
Republic of Korea
;
Tissue Donors
7.The Effects of Exendin-4 on IRS-2 Expression and Phosphorylation in INS-1 Cells.
Ji Hyun KIM ; Ji Won KIM ; Sung Yoon JEON ; Heon Seok PARK ; Dong Sik HAM ; Young Hye YOU ; Seung Hwan LEE ; Jae Hyoung CHO ; Mi Ja KANG ; Kang Woo LEE ; Hyuk Sang KWON ; Kun Ho YOON ; Bong Yun CHA ; Kwang Woo LEE ; Sung Koo KANG ; Ho Young SON
Korean Diabetes Journal 2008;32(2):102-111
BACKGROUND: Insulin receptor substrate 2 (IRS-2) is a key regulator of beta cell proliferation and apoptosis. This study was aimed to investigate effect of the glucolipotoxicity on apoptosis in INS-1 cell, and the effect of Exendin-4, a GLP-1 receptor agonist, on IRS-2 expression in the glucolipotoxicity induced INS-1 cell. The goal was to discover the new action mechanism and function of Exendin-4 in beta cell apoptosis. METHOD: INS-1 cells were cultured in glucolipotoxic condition for 2, 4 or 6 days and were categorized as G groups. Another group in which 50 nM Exendin-4 was added to INS-1 cells, cultured in glucolipotoxic condition, were named as Ex-4 groups. We investigated the expression of IRS-2 by RT-PCR, phosphorylated IRS-2 and phosphorylated Akt protein levels by western blot. We measured the apoptosis ratio of INS-1 cell in glucolipotoxic condition by TUNEL staining in both groups. RESULT: IRS-2 expression of INS-1 cells decreased with correlation to the time of exposure to glucolipotoxic condition. pIRS-2 and pAkt protein levels decreased in the similar pattern in glucolipotoxicity group. However, this effect of glucolipotoxicity on INS-1 cell was inhibited by the Exendin-4 treatment. In the Ex-4 groups, IRS-2 expression, pIRS-2 and pAkt protein levels remained at the similar level to low glucose condition state. Also, apoptosis induced by glucolipotoxicity was suppressed by Exendin-4 treatment significantly. CONCLUSION: We showed that the long-term treatment of Exendin-4 inhibited the apoptosis of beta cells significantly in glucolipotoxic condition and that this effect of Exendin-4 was related with IRS-2 and Akt among the beta cell's intracellular signal transduction pathway.
Apoptosis
;
Blotting, Western
;
Cell Proliferation
;
Cells, Cultured
;
Glucagon-Like Peptide 1
;
Glucagon-Like Peptide-1 Receptor
;
Glucose
;
In Situ Nick-End Labeling
;
Insulin Receptor Substrate Proteins
;
Peptides
;
Phosphorylation
;
Receptors, Glucagon
;
Signal Transduction
;
Venoms
8.Prevalence of Infectious Diseases in the Homeless Admitted to a Tertiary Care Center.
Se Woon HAM ; Kee Suk NAM ; Hye Jin NOH ; Kyung Deuk HONG ; Lae Seok HWANG ; Ji Hwan BANG ; Hyoung Shik SHIN
Infection and Chemotherapy 2007;39(4):183-188
BACKGROUND: Despite the expected high prevalence of several infectious diseases among the homeless, a majority of them have not received screening test and early treatment. MATERIALS AND METHODS: The subjects of this study were 269 homeless patients who had been hospitalized in the National Medical Center (Korea) between January 2002 and August 2004. Their medical histories and records were reviewed to analyze the prevalence and clinical characteristics of hepatitis B and C, syphilis, tuberculosis and HIV infection among them. RESULTS: The entire 269 homeless patients being hospitalized during the period of this study consist of 249 male patients and 19 female patients. For the prevalence of infectious diseases, HBV was seen in 15 of 228 patients (6.6%); HCV in 8 of 113 patients (7.1%); VDRL positive in 25 of 234 patients (10.7 %); HIV antibody positive in 2 of 130 (1.5%); and tuberculosis in 19 of 269 (7.1%). The number of patients who had the antibody to hepatitis B was 118 (51.7%). Of 28 patients hospitalized with the chief complaints of liver diseases and/or their complications, the number of cases infected with hepatitis B and C viruses was only 5 (17.9%). On the other hand, for patients with tuberculosis, 13 of 19 cases (68.4%) were hospitalized with the chief complaints associated with symptoms of pulmonary tuberculosis or enlarged lymph nodes. The number of patients with multiple infectious diseases was 9 in total. CONCLUSION: As expected, the prevalence of some infectious diseases were higher among the homeless inpatients, than non-homeless population. Proper screening tests in order to determine the presence of any infectious diseases among the patients and protect involved medical staff are necessary. Further, the government should take proactive measures to prevent the spread of infectious diseases in the aspect of public health.
Communicable Diseases*
;
Female
;
Hand
;
Hepatitis B
;
HIV
;
HIV Infections
;
Humans
;
Inpatients
;
Liver Diseases
;
Lymph Nodes
;
Male
;
Mass Screening
;
Medical Staff
;
Prevalence*
;
Public Health
;
Syphilis
;
Tertiary Care Centers*
;
Tertiary Healthcare*
;
Tuberculosis
;
Tuberculosis, Pulmonary
9.Prevalence of Infectious Diseases in the Homeless Admitted to a Tertiary Care Center.
Se Woon HAM ; Kee Suk NAM ; Hye Jin NOH ; Kyung Deuk HONG ; Lae Seok HWANG ; Ji Hwan BANG ; Hyoung Shik SHIN
Infection and Chemotherapy 2007;39(4):183-188
BACKGROUND: Despite the expected high prevalence of several infectious diseases among the homeless, a majority of them have not received screening test and early treatment. MATERIALS AND METHODS: The subjects of this study were 269 homeless patients who had been hospitalized in the National Medical Center (Korea) between January 2002 and August 2004. Their medical histories and records were reviewed to analyze the prevalence and clinical characteristics of hepatitis B and C, syphilis, tuberculosis and HIV infection among them. RESULTS: The entire 269 homeless patients being hospitalized during the period of this study consist of 249 male patients and 19 female patients. For the prevalence of infectious diseases, HBV was seen in 15 of 228 patients (6.6%); HCV in 8 of 113 patients (7.1%); VDRL positive in 25 of 234 patients (10.7 %); HIV antibody positive in 2 of 130 (1.5%); and tuberculosis in 19 of 269 (7.1%). The number of patients who had the antibody to hepatitis B was 118 (51.7%). Of 28 patients hospitalized with the chief complaints of liver diseases and/or their complications, the number of cases infected with hepatitis B and C viruses was only 5 (17.9%). On the other hand, for patients with tuberculosis, 13 of 19 cases (68.4%) were hospitalized with the chief complaints associated with symptoms of pulmonary tuberculosis or enlarged lymph nodes. The number of patients with multiple infectious diseases was 9 in total. CONCLUSION: As expected, the prevalence of some infectious diseases were higher among the homeless inpatients, than non-homeless population. Proper screening tests in order to determine the presence of any infectious diseases among the patients and protect involved medical staff are necessary. Further, the government should take proactive measures to prevent the spread of infectious diseases in the aspect of public health.
Communicable Diseases*
;
Female
;
Hand
;
Hepatitis B
;
HIV
;
HIV Infections
;
Humans
;
Inpatients
;
Liver Diseases
;
Lymph Nodes
;
Male
;
Mass Screening
;
Medical Staff
;
Prevalence*
;
Public Health
;
Syphilis
;
Tertiary Care Centers*
;
Tertiary Healthcare*
;
Tuberculosis
;
Tuberculosis, Pulmonary
10.Sound Localization in Subjects with a Unilateral Hearing Loss according to Hearing Loss.
Hyoung Seok HAM ; Sang Yoon SONG ; Moo Suh PARK
Korean Journal of Otolaryngology - Head and Neck Surgery 1999;42(8):961-966
BACKGROUND AND OBJECTIVES: Sound localization in subjects with normal hearing is done by recognition of interaural difference of time, intensity and phase of sound source. Individuals with unilateral hearing losses, deprived of the binaural cues, are expected to have difficulty in localizing sound. The purpose of the research is to investigate the sound localizing ability in subjects with unilateral hearing losses to localize sound in horizontal plane by comparing with normal control group, and to know the effects of age, gender, stimulus type and hearing level. MATERIALS: Two groups of subjects participated in this study. The first group consisted of 60 normal hearing adults, in each age groups of 10 subjects, ranging from teens to sixties. The second group consisted of 50 subjects with unilateral hearing losses. METHODS: Sound localization ability was assessed by means of an array of eight loudspeakers positioned at the azimuth of 45 degrees each in the horizontal plane at a distance of 100 cm from the subject. The stimuli consisted of speech noise, narrow band noise centered at 500 Hz and 4000 Hz, pure tone of 500 Hz and 4000 Hz at the level of 45 dB HL for 5 seconds. RESULTS: 1) Speech noise was the most easily detected stimulus (p<0.001). 2) The age and gender did not affect significantly to the ability to localize sound (p>0.05). 3) The localization errors for speech noise increased significantly as hearing threshold increased in patients with unilateral hearing losses (p<0.001). CONCLUSION: The results suggest that speech noise is the most easily detected stimulus in directional discrimination test and that the ability of sound localization is degraded as hearing threshold is increased for patients with unilateral hearing losses.
Adolescent
;
Adult
;
Cues
;
Discrimination (Psychology)
;
Hearing Loss*
;
Hearing Loss, Unilateral*
;
Hearing*
;
Humans
;
Noise
;
Sound Localization*

Result Analysis
Print
Save
E-mail